Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Wayne State University
mi
from
Detroit, MI
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
RTI International
mi
from
Durham, NC
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
RTI International
mi
from
Durham, NC
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Univeristy of Pennsylvania
mi
from
Philadelphia, PA
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Univeristy of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Inositol to Reduce Retinopathy of Prematurity
INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Center for Excellence in Eye Care
mi
from
Miami, FL
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Center for Excellence in Eye Care
mi
from
Miami, FL
Click here to add this to my saved trials
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Stulting Research Center at Woolfson Eye Institute
mi
from
Atlanta, GA
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Stulting Research Center at Woolfson Eye Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
mi
from
Rockville, MD
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
mi
from
Rockville, MD
Click here to add this to my saved trials
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Talamo Hatch Laser Eye Consultants, LLC
mi
from
Boston, MA
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Talamo Hatch Laser Eye Consultants, LLC
mi
from
Boston, MA
Click here to add this to my saved trials
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
Cleveland Eye Clinic
mi
from
Brecksville, OH
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
Cleveland Eye Clinic
mi
from
Brecksville, OH
Click here to add this to my saved trials
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated:  12/31/1969
TLC Laser Eye Center
mi
from
Fairfax, VA
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status: Enrolling
Updated: 12/31/1969
TLC Laser Eye Center
mi
from
Fairfax, VA
Click here to add this to my saved trials
Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.
Status: Enrolling
Updated:  12/31/1969
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
UC Irvine Department of Ophthalmology
mi
from
Irvine, CA
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
UC Irvine Department of Ophthalmology
mi
from
Irvine, CA
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Gordon -Weiss Vision Institute
mi
from
San Diego, CA
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Gordon -Weiss Vision Institute
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Durrie Vision
mi
from
Overland Park, KA
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Durrie Vision
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
mi
from
Waltham, MA
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Waltham, MA
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Hersh Vision Group
mi
from
Teaneck, NJ
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Hersh Vision Group
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
UPMC Eye Center
mi
from
Pittsburgh, PA
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
UPMC Eye Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Vance Thompson Vision
mi
from
Sioux Falls, SD
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Vance Thompson Vision
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Focal Point Vision
mi
from
San Antonio, TX
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Focal Point Vision
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Hoopes Vision
mi
from
Draper, UT
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Hoopes Vision
mi
from
Draper, UT
Click here to add this to my saved trials
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
See Clearly Vision
mi
from
McLean, VA
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
See Clearly Vision
mi
from
McLean, VA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Arizona Retina and Vitreous Consultants
mi
from
Phoenix, AZ
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Arizona Retina and Vitreous Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Jones Eye Institute/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Jones Eye Institute/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Retinal Diagnostic Center
mi
from
Campbell, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Retinal Diagnostic Center
mi
from
Campbell, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
South Coast Retina Center
mi
from
Long Beach, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
South Coast Retina Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Desert, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
mi
from
Westlake Village, CA
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
mi
from
Westlake Village, CA
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
New England Retina Associates
mi
from
Norwich, CT
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
New England Retina Associates
mi
from
Norwich, CT
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
University of Florida College of Med., Department of Ophthalmology
mi
from
Jacksonville, FL
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
University of Florida College of Med., Department of Ophthalmology
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Florida Retina Consultants
mi
from
Lakeland, FL
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Florida Retina Consultants
mi
from
Lakeland, FL
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Retina Macula Specialists of Miami
mi
from
Miami, FL
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Retina Macula Specialists of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated:  12/31/1969
Ocala Eye Retina Consultants
mi
from
Ocala, FL
Treatment for CI-DME in Eyes With Very Good VA Study
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Enrolling
Updated: 12/31/1969
Ocala Eye Retina Consultants
mi
from
Ocala, FL
Click here to add this to my saved trials